{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:15:00Z","timestamp":1762157700159,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,6,30]],"date-time":"2014-06-30T00:00:00Z","timestamp":1404086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"National Science and Technology Major Project of the Ministry of Science and Technology of China","award":["2012ZX09301002-001-015","2012ZX10004501-004-001"],"award-info":[{"award-number":["2012ZX09301002-001-015","2012ZX10004501-004-001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.apsb.2014.06.008","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T22:15:35Z","timestamp":1405462535000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The antiviral effect of jiadifenoic acids C against coxsackievirus B3"],"prefix":"10.1016","volume":"4","author":[{"given":"Miao","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2014.06.008_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14712590903379502","article-title":"Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines","volume":"10","author":"Kim","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.apsb.2014.06.008_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/jvi.71.1.595-600.1997","article-title":"Tyrosine phosphorylation events during coxsackievirus B3 replication","volume":"71","author":"Huber","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2014.06.008_bib3","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.3390\/molecules16108475","article-title":"Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections","volume":"16","author":"Fechner","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2014.06.008_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.01.013","article-title":"Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice","volume":"104","author":"Koho","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2014.06.008_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10495-006-0015-y","article-title":"Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3","volume":"12","author":"Martin","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.apsb.2014.06.008_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/hv.7.4.14422","article-title":"Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy","volume":"7","author":"Kim","year":"2011","journal-title":"Human Vaccines"},{"key":"10.1016\/j.apsb.2014.06.008_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2007.05.007","article-title":"Coxsackievirus B3 modulates cell death by downregulating activating transcription factor 3 in HeLa cells","volume":"130","author":"Hwang","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.apsb.2014.06.008_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930500484906","article-title":"Autoimmunity in coxsackievirus B3 induced myocarditis","volume":"39","author":"Huber","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.apsb.2014.06.008_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.virol.2012.08.040","article-title":"A functional nuclear localization sequence in the VP1 capsid protein of coxsackievirus B3","volume":"433","author":"Wang","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.apsb.2014.06.008_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/dki055","article-title":"Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication","volume":"55","author":"Makarov","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.apsb.2014.06.008_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1743-422X-9-312","article-title":"Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production","volume":"9","author":"Zhang","year":"2012","journal-title":"Virology J"},{"key":"10.1016\/j.apsb.2014.06.008_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1517\/13543784.10.2.369","article-title":"Pleconaril: a novel antipicornaviral drug","volume":"10","author":"Romero","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.apsb.2014.06.008_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1086\/318452","article-title":"Treatment of potentially life-threatening enterovirus infections with pleconaril","volume":"32","author":"Rotbart","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apsb.2014.06.008_bib14","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/314758","article-title":"Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants","volume":"179","author":"Groarke","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2014.06.008_bib15","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.00227-06","article-title":"Enteroviral meningitis: natural history and outcome of pleconaril therapy","volume":"50","author":"Desmond","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2014.06.008_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2008.09.002","article-title":"New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3","volume":"81","author":"Schmidtke","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.apsb.2014.06.008_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dki263","article-title":"Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment","volume":"56","author":"Schmidtke","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.apsb.2014.06.008_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.tet.2012.11.089","article-title":"Anti-coxsackie virus B diterpenes from the roots of Illicium jiadifengpi","volume":"69","author":"Zhang","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.apsb.2014.06.008_bib19","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/JVI.75.4.1761-1769.2001","article-title":"Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir","volume":"75","author":"Sarisky","year":"2001","journal-title":"J Virology"},{"key":"10.1016\/j.apsb.2014.06.008_bib20","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/AAC.06050-12","article-title":"Antiviral effects of small interfering RNA simultaneously inducing RNA interference and type 1 interferon in coxsackievirus myocarditis","volume":"56","author":"Ahn","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2014.06.008_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/10286020.2013.770737","article-title":"The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro","volume":"15","author":"Wang","year":"2013","journal-title":"J Asian Nat Prod Res"},{"key":"10.1016\/j.apsb.2014.06.008_bib22","doi-asserted-by":"crossref","first-page":"10364","DOI":"10.1128\/JVI.05022-11","article-title":"Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase","volume":"85","author":"Gazina","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2014.06.008_bib23","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.00631-08","article-title":"The crystal structure of coxsackievirus B3 RNA-dependent RNA polymerase in complex with its protein primer VPg confirms the existence of a second VPg binding site on Picornaviridae polymerases","volume":"82","author":"Gruez","year":"2008","journal-title":"J Virol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383514000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383514000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:33:59Z","timestamp":1761928439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383514000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2211383514000604"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2014.06.008","relation":{},"ISSN":["2211-3835"],"issn-type":[{"type":"print","value":"2211-3835"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antiviral effect of jiadifenoic acids C against coxsackievirus B3","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2014.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}